EMS, officially known as EMS Sigma Pharma, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Brazil. Founded in 1964, the company has established a strong presence across various regions, including Latin America and Europe, and is renowned for its commitment to quality and innovation.
Specialising in the production of generic and branded medications, EMS offers a diverse portfolio that includes prescription drugs, over-the-counter products, and specialised formulations. Their unique approach to research and development has positioned them as a market leader, consistently delivering high-quality pharmaceuticals that meet rigorous regulatory standards.
With a focus on sustainability and technological advancement, EMS has achieved significant milestones, including numerous certifications and awards that underscore its reputation for excellence in the pharmaceutical sector.
-4 vs industry average
EMS’s score of 34 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at EMS?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
EMS's reported carbon emissions
EMS, a pharmaceutical preparation manufacturing company headquartered in Brazil (BR), reported its environmental data for several years. In 2024, the company's total emissions were approximately 13.0 billion kg CO2e, encompassing Scope 1 (about 22 million kg CO2e), Scope 2 (about 84 million kg CO2e), and Scope 3 (about 12.9 billion kg CO2e). For the reporting year 2023, EMS recorded total emissions of approximately 13.5 billion kg CO2e. This included Scope 1 emissions of about 20 million kg CO2e, Scope 2 emissions of about 85 million kg CO2e, and Scope 3 emissions of about 13.4 billion kg CO2e. In 2022, the company's total emissions stood at approximately 41.5 million kg CO2e, with Scope 1 emissions around 18.2 million kg CO2e, Scope 2 emissions around 3.7 million kg CO2e, and Scope 3 emissions around 3.8 million kg CO2e. EMS's emissions data is cascaded from its parent company, EMS S.A., reflecting its position as a current subsidiary. While specific reduction targets and climate pledges for EMS are not detailed in the provided information, the company's reporting across all scopes indicates a commitment to tracking its environmental impact. The company's sustainability reports, such as the one for 2024, are available for further review. Notably, Scope 3 emissions, particularly purchased goods and services, are identified as missing data points in their reporting.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
EMS’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for EMS yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
EMS
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project